491 related articles for article (PubMed ID: 28109674)
21. Irreversible Electroporation For Hepatocellular Carcinoma: Longer-Term Outcomes At A Single Centre.
Freeman E; Cheung W; Kavnoudias H; Majeed A; Kemp W; Roberts SK
Cardiovasc Intervent Radiol; 2021 Feb; 44(2):247-253. PubMed ID: 33051707
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous Ablation of Hepatic Tumors Using Irreversible Electroporation: A Prospective Safety and Midterm Efficacy Study in 34 Patients.
Niessen C; Beyer LP; Pregler B; Dollinger M; Trabold B; Schlitt HJ; Jung EM; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2016 Apr; 27(4):480-6. PubMed ID: 26922979
[TBL] [Abstract][Full Text] [Related]
23. Ultrasound-guided percutaneous irreversible electroporation of hepatic and abdominal tumors not eligible for surgery or thermal ablation: a western report on safety and efficacy.
Giorgio A; Amendola F; Calvanese A; Ingenito E; Santoro B; Gatti P; Ciracì E; Matteucci P; Giorgio V
J Ultrasound; 2019 Mar; 22(1):53-58. PubMed ID: 30843171
[TBL] [Abstract][Full Text] [Related]
24. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes.
Cheung W; Kavnoudias H; Roberts S; Szkandera B; Kemp W; Thomson KR
Technol Cancer Res Treat; 2013 Jun; 12(3):233-41. PubMed ID: 23369152
[TBL] [Abstract][Full Text] [Related]
25. Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series.
Sutter O; Calvo J; N'Kontchou G; Nault JC; Ourabia R; Nahon P; Ganne-Carrié N; Bourcier V; Zentar N; Bouhafs F; Sellier N; Diallo A; Seror O
Radiology; 2017 Sep; 284(3):877-886. PubMed ID: 28453431
[TBL] [Abstract][Full Text] [Related]
26. Irreversible Electroporation for Unresectable Hepatocellular Carcinoma: Initial Experience.
Kalra N; Gupta P; Gorsi U; Bhujade H; Chaluvashetty SB; Duseja A; Singh V; Dhiman RK; Chawla YK; Khandelwal N
Cardiovasc Intervent Radiol; 2019 Apr; 42(4):584-590. PubMed ID: 30697637
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous Irreversible Electroporation (IRE) of Hepatic Malignancy: A Bi-institutional Analysis of Safety and Outcomes.
Mafeld S; Wong JJ; Kibriya N; Stenberg B; Manas D; Bassett P; Aslam T; Evans J; Littler P
Cardiovasc Intervent Radiol; 2019 Apr; 42(4):577-583. PubMed ID: 30465255
[TBL] [Abstract][Full Text] [Related]
28. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy.
Scheffer HJ; Nielsen K; de Jong MC; van Tilborg AA; Vieveen JM; Bouwman AR; Meijer S; van Kuijk C; van den Tol PM; Meijerink MR
J Vasc Interv Radiol; 2014 Jul; 25(7):997-1011; quiz 1011. PubMed ID: 24656178
[TBL] [Abstract][Full Text] [Related]
29. Irreversible electroporation for colorectal cancer liver metastasis: a review.
Koethe Y; Wilson N; Narayanan G
Int J Hyperthermia; 2022; 39(1):682-687. PubMed ID: 35469520
[TBL] [Abstract][Full Text] [Related]
30. Irreversible electroporation of hepatocellular carcinoma and colorectal cancer liver metastases: A nationwide multicenter study with short- and long-term follow-up.
Frühling P; Stillström D; Holmquist F; Nilsson A; Freedman J
Eur J Surg Oncol; 2023 Nov; 49(11):107046. PubMed ID: 37716017
[TBL] [Abstract][Full Text] [Related]
31. MWA Versus RFA for Perivascular and Peribiliary CRLM: A Retrospective Patient- and Lesion-Based Analysis of Two Historical Cohorts.
van Tilborg AA; Scheffer HJ; de Jong MC; Vroomen LG; Nielsen K; van Kuijk C; van den Tol PM; Meijerink MR
Cardiovasc Intervent Radiol; 2016 Oct; 39(10):1438-46. PubMed ID: 27387188
[TBL] [Abstract][Full Text] [Related]
32. Irreversible electroporation for the ablation of liver tumors: are we there yet?
Charpentier KP
Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618
[TBL] [Abstract][Full Text] [Related]
33. Irreversible electroporation ablation of malignant hepatic tumors: subacute and follow-up CT appearance of ablation zones.
Dollinger M; Jung EM; Beyer L; Niessen C; Scheer F; Müller-Wille R; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2014 Oct; 25(10):1589-94. PubMed ID: 25156648
[TBL] [Abstract][Full Text] [Related]
34. Irreversible Electroporation in the Treatment of Hepatocellular Carcinoma.
Lencioni R; Crocetti L; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):135-9. PubMed ID: 26365542
[TBL] [Abstract][Full Text] [Related]
35. Color Coded Perfusion Imaging with Contrast Enhanced Ultrasound (CEUS) for Post-Interventional Success Control Following Irreversible Electroporation (IRE) of Primary and Secondary Malignant Liver Lesions.
Rennert J; Wiesinger I; Schicho A; Wiggermann P; Stroszczynski C; Beyer LP; Jung EM
J Gastrointestin Liver Dis; 2019 Sep; 28(3):311-318. PubMed ID: 31517328
[TBL] [Abstract][Full Text] [Related]
36. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
37. Biliary complications and efficacy after ablation of peribiliary tumors using irreversible electroporation (IRE) or radiofrequency ablation (RFA).
Thamtorawat S; Patanawanitkul R; Rojwatcharapibarn S; Chaiyasoot W; Tongdee T; Yodying J; Sorotpinya S
Int J Hyperthermia; 2022; 39(1):751-757. PubMed ID: 35649727
[TBL] [Abstract][Full Text] [Related]
38. Colorectal liver metastases: making the unresectable resectable using irreversible electroporation for microscopic positive margins - a case report.
Schoellhammer HF; Goldner B; Merchant SJ; Kessler J; Fong Y; Gagandeep S
BMC Cancer; 2015 Apr; 15():271. PubMed ID: 25886376
[TBL] [Abstract][Full Text] [Related]
39. Peri-tumoral Metallic Implants Reduce the Efficacy of Irreversible Electroporation for the Ablation of Colorectal Liver Metastases.
Cornelis FH; Cindrič H; Kos B; Fujimori M; Petre EN; Miklavčič D; Solomon SB; Srimathveeravalli G
Cardiovasc Intervent Radiol; 2020 Jan; 43(1):84-93. PubMed ID: 31385006
[TBL] [Abstract][Full Text] [Related]
40. Factors associated with short-term local recurrence of liver cancer after percutaneous ablation using irreversible electroporation: a prospective single-center study.
Niessen C; Igl J; Pregler B; Beyer L; Noeva E; Dollinger M; Schreyer AG; Jung EM; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2015 May; 26(5):694-702. PubMed ID: 25812712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
